- WHAT IT IS
- A passive, unpowered exoskeleton that routes 65% of upper-body weight off the spine to the ground through a self-locking knee, deliberately leaving part of the load to the wearer's own muscles. The design is frozen in CAD with first-order simulation.
- VALIDATED
- Market position, the competitive gap and unit economics rest on published data and the frozen design, returning a 46.7% retail gross margin. The self-locking knee holds a 1.50× anti-buckle margin in first-order simulation.
- NEXT
- A 5-unit bench build tests the knee brake and composite frame for ₹5–8 lakh in a single build-and-test cycle, ahead of a 12-week clinical pilot.
Cost, margin, breakeven and market-size figures are modelled from the project's own cost model and published market data.
THE OPPORTUNITY
01Product Overview: 65% Off the Spine
Orvyn is specified to route 65% of upper-body weight to the ground with zero electronics, keeping the wearer's muscles working 1.
Orvyn is worn on the back and legs by adults aged 65–80 with lumbar degeneration or kyphosis. Upper-body weight passes from a rigid articulated posterior spine into dual thigh perches, then through a single-axis disc-hub knee and over-shoe footplates to the ground, bypassing the spine 1.
The second buyer is institutional: rehabilitation departments and elderly-care homes that carry the liability for caregiver injury. The design is frozen at version 0.6.0, and the 6.50 kg aluminium-and-steel frame is moving into a lighter composite 1.
02The Problem: 29% Severely Disabled
Of India's 40 million elderly with chronic lumbar pain, one geriatric study found 29% severely disabled, unable to perform daily tasks 2 3 4.
With age, the muscles that hold posture stop carrying load, so bones and discs take it instead. Standing beyond ten minutes brings severe pain, a hunched stance and a rising risk of falls.
Elderly low back pain runs at 21–75% 3, and 29% of geriatric patients in a Delhi tertiary-hospital study could not perform ordinary daily tasks 4. Older adults name active independence as the goal of spine care, and describe pain stopping them from what others ask of them 5.
The frame is cheaper to make now. Carbon fibre fell from USD 33 per kg in 2022 to USD 12 per kg by late 2024, and automated layup cut part costs by 20–30% 6, bringing a passive frame within a ₹35,000–40,000 retail band that powered devices cannot approach 7.
03Hypothesis Pivot: I Killed Full Offload
I killed full offload once clinical observation showed it wastes muscle and builds dependence, and rebuilt Orvyn on partial offload.
The original belief was mechanical: remove the load entirely. Beneath it sat a second assumption, that the problem was age itself rather than a specific failure of the muscles that carry posture.
Direct clinical observation across a professional network overturned both. Full offload lets the supporting muscles waste, which deepens the dependence the device exists to relieve. I repositioned the design on partial offload and moved powered actuation to a later phase, accepting a less dramatic product for one that keeps the wearer strong.
04Market Position: 1–2 million Self-Paying Buyers
From 153 million Indians aged 60 and over, 40 million carry chronic lumbar pain, and 1–2 million of them can pay ₹35,000–40,000 for the device themselves 2 3 7.
153 million
INDIANS AGED 60 AND OVER
About 40% sit in the poorest wealth quintile, and one in five has no income of their own 2
40 million
CHRONIC LUMBAR PAIN
A 26% share of the base, inside the 21–75% published elderly prevalence 3
1–2 million
SELF-PAYING, TIER 1
The retail ceiling; the early market is a fraction of it, reached through institutions 7
05Competitive Landscape: An Unserved Spine
Powered exoskeletons remove all load at USD 60,000–110,000 8; passive wearable chairs serve factory standing, not elderly spines 9 10.
| OPTION | OFFLOAD | BUILT FOR |
|---|---|---|
| Powered medical exoskeletons: Ekso, ReWalk | Full | Paralysis and spinal-cord injury, at USD 60,000–110,000 8 |
| Passive wearable chairs: noonee 9, Archelis 10 | Partial, near-seated | Factory and surgical standing |
| Lumbar braces | Minimal | General back support |
| Walkers and canes | None; balance only | Mobility, not spinal offload |
| Human caregivers, or nothing | None | The default; over 40% of older people struggle to rise from sitting 11 |
| Orvyn (specified) | Partial, upright | The degenerated elderly spine, in daily living and care |
OPTION
Powered medical exoskeletons: Ekso, ReWalk
- BUILT FOR
- Paralysis and spinal-cord injury, at USD 60,000–110,000 8
- OFFLOAD
- Full
Passive wearable chairs: noonee 9, Archelis 10
- BUILT FOR
- Factory and surgical standing
- OFFLOAD
- Partial, near-seated
Lumbar braces
- BUILT FOR
- General back support
- OFFLOAD
- Minimal
Walkers and canes
- BUILT FOR
- Mobility, not spinal offload
- OFFLOAD
- None; balance only
Human caregivers, or nothing
- BUILT FOR
- The default; over 40% of older people struggle to rise from sitting 11
- OFFLOAD
- None
Orvyn (specified)
- BUILT FOR
- The degenerated elderly spine, in daily living and care
- OFFLOAD
- Partial, upright
Partial offload alone is not the gap, since passive occupational chairs offload partially too. Orvyn occupies the combination incumbents miss: the degenerated elderly spine as the target, upright posture restored, and the home and care setting instead of the factory floor.
The barriers to entry are regulatory and clinical rather than technical: CDSCO device classification, ISO 10993 biocompatibility, ISO 13485 and 14971 quality and risk systems, and the clinical trust to sell into hospitals and care homes.
06Strategic Bet: Partial Offload Over the Easier Sell
I chose partial offload over the full offload competitors sell, accepting a less impressive demonstration for a user who stays stronger.
Full offload is the easier sell and the worse outcome, because it wastes muscle and builds dependence. I excluded electronics and actuators from Phase 1 and held the sensor layer as a later add-on, accepting manual measurement through the pilot.
I cut the front chest and shoulder yoke, trading forward-lean offload for unrestricted movement and wear under clothing. I replaced a polycentric four-bar knee with a single-axis disc hub, accepting a simpler motion path for fewer parts and one integrated brake. The hardest call was how much load to take away.
THE PRODUCT
07Product Specification: A Load-Free Harness
The harness retains the torso without bearing load or compressing the chest, so breathing stays unrestricted and the frame wears under clothing.
A rigid articulated posterior spine sits against the back in a padded panel, while shoulder straps and a hip belt hold the torso without carrying weight. The spine column, joints, disc-hub knee, thigh perches, footplates and open-patella support are purpose-made; springs, bushings, webbing, buckles and fasteners are commodity 1.
Fully passive, the device has mechanical states only: the knee brake engages under load and releases in swing with zero drag. Sizing runs small, medium and large on global anthropometrics, with Indian body data scheduled for Phase 2.




08Technical Validation: The 1.50× Knee Margin
The stance-control knee is the element the bench decides: a 5-unit build at ₹5–8 lakh confirms the 1.50× anti-buckle margin before any tooling spend 1 7.
SIMULATED
Anti-buckle margin of 1.50×, corrected from a failing 0.80× before the geometry froze
First-order simulation 1; bench load test across 5 units
SIMULATED
The knee holds its lock through 1.0 million fatigue cycles
First-order fatigue simulation 1; rig cycling on the bench build
SPECIFIED
The brake engages in under 30 ms under load and releases in swing with zero drag
Bench rig across 5 units
SPECIFIED
The composite frame carries 893 N per leg at target weight
Bench and rig load test, with composite moulder quotes alongside
SPECIFIED
A 111 g disc-hub knee per side with 0–110° flexion and an integrated Ø40 mm 4130-steel brake drum at a 25° cam, giving 8.9 N·m anti-buckle moment
Stance-control principle from knee orthotics; dimensioned component drawings with tolerances 1
THE BUSINESS CASE
09Unit Economics: 46.7% Retail Gross Margin
At a ₹37,500 retail midpoint against a ₹20,000 bill of materials, each unit contributes ₹17,500, a 46.7% gross margin 7.
| LINE | RETAIL | REIMBURSEMENT |
|---|---|---|
| Price, midpoint | ₹37,500 | ₹27,500 |
| Bill of materials, legacy midpoint | ₹20,000 | ₹20,000 |
| Contribution per unit | ₹17,500 | ₹7,500 |
| Gross margin | 46.7% | 27.3% |
| Breakeven, tooling only | 77 units | 180 units |
| Breakeven, full upfront | 114 units | 267 units |
LINE
Price, midpoint
- RETAIL
- ₹37,500
- REIMBURSEMENT
- ₹27,500
Bill of materials, legacy midpoint
- RETAIL
- ₹20,000
- REIMBURSEMENT
- ₹20,000
Contribution per unit
- RETAIL
- ₹17,500
- REIMBURSEMENT
- ₹7,500
Gross margin
- RETAIL
- 46.7%
- REIMBURSEMENT
- 27.3%
Breakeven, tooling only
- RETAIL
- 77 units
- REIMBURSEMENT
- 180 units
Breakeven, full upfront
- RETAIL
- 114 units
- REIMBURSEMENT
- 267 units
Revenue is a one-time hardware sale, with institutional placement and reimbursement alongside retail. Through reimbursement at ₹27,500, margin falls to 27.3%, and against Phase-2 tooling of ₹13.5 lakh, breakeven runs from 77 to 267 units 7.
The composite bill of materials moves the margin most. At ₹30,000, retail margin thins to 20.0% and reimbursement margin falls to −9.1%; reimbursement reaches zero at a ₹27,500 BOM, and retail at ₹37,500 7. Channel mix is the second lever, and whether ₹35,000–40,000 is the shelf price or the realised price decides if a distributor margin sits between price and contribution.
Reimbursement Margin Turns Negative Once the BOM Passes ₹27,500
- Retail gross margin
- Reimbursement gross margin
10Success Metrics: 5 Days a Week for 12 Weeks
The decisive metric is sustained wear: a majority of pilot participants wearing Orvyn 5 or more days a week across a 12-week pilot 7.
5 days
WORN EACH WEEK
By a majority of participants; independence accrues only if the device is worn, not abandoned after novelty
2–3 hours
WORN EACH DAY
Logged through wear diaries and clinical follow-up until the Phase-2 sensor layer tracks it
12 weeks
PILOT LENGTH
Counter-metric: any decline in strength or daily-living score on validated sit-to-stand, mobility and disability scales
11Distribution: One Account Places 10–30 Units
One institutional account places 10–30 units at once, landing acquisition cost at ₹1,667–15,000 per unit 7.
The channel is institutional and clinical, not direct to consumer. Users are already under observation in hospitals, and care institutions hold a direct interest in resident mobility. One placement reaches many patients where Tier-1 consumers are diffuse, and clinical endorsement is the on-ramp to reimbursement.
Winning an account takes a multi-month cycle of field sales, demonstrations and a pilot placement, costing ₹50,000–1,50,000 7. Acquisition cost per unit must stay below contribution of ₹7,500 to ₹17,500, and at the top of its range it exceeds the reimbursement contribution.
Acquisition Cost per Unit Can Pass the ₹7,500 Reimbursement Contribution
12Risk Gates: Three Thresholds Before Tooling
Three non-overlapping gates, technical, financial and market, each decide whether the programme advances or redesigns before tooling spend.
| GATE | ADVANCES IF | SAMPLE | TIMELINE | ON EITHER SIDE |
|---|---|---|---|---|
| Technical · knee and composite frame | The brake engages under 30 ms, holds 1.50× or more and survives 1.0 million cycles without losing lock; the composite carries 893 N per leg at target weight 1 | 5 units, bench and rig | One build-and-test cycle | Pass advances to the clinical pilot; fail forces redesign before tooling |
| Financial · composite bill of materials | A composite BOM at or below ₹22,000 holds both channels; above ₹27,500 reimbursement goes negative 7 | 3 or more moulder quotes | During the 5-unit build | At or below, tooling proceeds; above, the material or the reimbursement channel is dropped before tooling |
| Market · institutional demand | The first pilot converts at least one paid order and a majority sustain adherence over 12 weeks 7 | 1–3 accounts, 10–20 participants | 12-week pilot after the bench | Met, the institution-led market scales; missed, go-to-market is reworked before manufacturing setup |
GATE
Technical · knee and composite frame
- ADVANCES IF
- The brake engages under 30 ms, holds 1.50× or more and survives 1.0 million cycles without losing lock; the composite carries 893 N per leg at target weight 1
- ON EITHER SIDE
- Pass advances to the clinical pilot; fail forces redesign before tooling
- SAMPLE
- 5 units, bench and rig
- TIMELINE
- One build-and-test cycle
Financial · composite bill of materials
- ADVANCES IF
- A composite BOM at or below ₹22,000 holds both channels; above ₹27,500 reimbursement goes negative 7
- ON EITHER SIDE
- At or below, tooling proceeds; above, the material or the reimbursement channel is dropped before tooling
- SAMPLE
- 3 or more moulder quotes
- TIMELINE
- During the 5-unit build
Market · institutional demand
- ADVANCES IF
- The first pilot converts at least one paid order and a majority sustain adherence over 12 weeks 7
- ON EITHER SIDE
- Met, the institution-led market scales; missed, go-to-market is reworked before manufacturing setup
- SAMPLE
- 1–3 accounts, 10–20 participants
- TIMELINE
- 12-week pilot after the bench
A failed brake or fatigue result stops the programme before any pilot. Within the pilot, a device-attributable fall, a skin injury, or a cohort-level decline in muscle strength or daily-living score ends it and forces redesign.
13Scale Trajectory: Breakeven at 77–267 Units
Breakeven arrives between 77 and 267 units, against a self-paying ceiling of 1–2 million buyers 7.
The addressable pool is 40 million elderly with chronic lumbar pain. The 1–2 million self-paying buyers set the retail ceiling, and the early market is a fraction of that, reached institution-first 7.
The Phase-2 sensor layer is the adjacent product. It turns the passive frame into an instrumented device and opens the monitoring product and rental model held for later phases.
THE OUTCOME
14What This Unlocked: Problem Before Business
I set a sequencing rule after the reframe: fix the true problem, design against it, and only then work out how the device sells.
The original execution ran the wrong way round, with work on how the device would sell and scale before the core problem was firmly in hand. Reframing before committing the design is what changed the outcome.
The transferable output is a sequence: reframe until the true problem is in hand, iterate the design against that reframe instead of defending the first concept, and solve the problem before designing the business. Its engineering counterpart is full load and fatigue simulation before geometry freezes, the discipline that caught the failing 0.80× brake margin in a model rather than in hardware 1.
For the person who cannot stand at a kitchen counter beyond a few minutes today, the change is daily: cooking and moving about the home upright, with their own muscles still carrying part of the load.
15Build Pack: A Costed Path to the Bench
Seven deliverables are complete, from frozen CAD to the regulatory pathway, and eight advance next, starting with a 5-unit bench build at ₹5–8 lakh 7.
| COMPLETE | STATE |
|---|---|
| 3D CAD and final geometry | Design-frozen at v0.6.0 |
| Renders | Front, rear, side and detail views of the frozen design |
| Dimensioned component drawings | Knee, brake drum, footplate, patella pad and hip pivot, with tolerances |
| First-order simulation | Knee load and fatigue to 1.0 million cycles; brake margin 1.50× |
| Cost and market model | Margins, breakeven, sensitivity, bottom-up sizing and the competitive set |
| Engineering reports | Back support (v0.3); knee, ankle, footplate and strap (v0.4) |
| Regulatory pathway | CDSCO and DCGI, ISO 10993, ISO 13485 and 14971, IRB |
COMPLETE
3D CAD and final geometry
- STATE
- Design-frozen at v0.6.0
Renders
- STATE
- Front, rear, side and detail views of the frozen design
Dimensioned component drawings
- STATE
- Knee, brake drum, footplate, patella pad and hip pivot, with tolerances
First-order simulation
- STATE
- Knee load and fatigue to 1.0 million cycles; brake margin 1.50×
Cost and market model
- STATE
- Margins, breakeven, sensitivity, bottom-up sizing and the competitive set
Engineering reports
- STATE
- Back support (v0.3); knee, ankle, footplate and strap (v0.4)
Regulatory pathway
- STATE
- CDSCO and DCGI, ISO 10993, ISO 13485 and 14971, IRB
| ADVANCING NEXT | UNLOCKS | COST · TIMING |
|---|---|---|
| Bench build, 5 units | First validation of brake, fatigue and composite frame | ₹5–8 lakh; one build-and-test cycle |
| Composite bill-of-materials costing | The true per-unit margin | Within the bench build |
| Composite material and weight target | A wearable weight for an elderly user | — |
| Assembly sequence, fail-safe specification, setup and end-of-life detail | Manufacturability and the pilot safety case | — |
| Clinical pilot, 12 weeks, 10–20 participants | The first demand signal and measured outcome | After bench validation |
| Suppliers, lead times, packing and shipping | Manufacturing readiness | — |
| Indian anthropometric sizing and the sensor layer | Fit for the target user; automatically tracked metrics | Phase 2 |
| Phase-2 tooling | Volume production | ₹12–15 lakh |
ADVANCING NEXT
Bench build, 5 units
- UNLOCKS
- First validation of brake, fatigue and composite frame
- COST · TIMING
- ₹5–8 lakh; one build-and-test cycle
Composite bill-of-materials costing
- UNLOCKS
- The true per-unit margin
- COST · TIMING
- Within the bench build
Composite material and weight target
- UNLOCKS
- A wearable weight for an elderly user
- COST · TIMING
- —
Assembly sequence, fail-safe specification, setup and end-of-life detail
- UNLOCKS
- Manufacturability and the pilot safety case
- COST · TIMING
- —
Clinical pilot, 12 weeks, 10–20 participants
- UNLOCKS
- The first demand signal and measured outcome
- COST · TIMING
- After bench validation
Suppliers, lead times, packing and shipping
- UNLOCKS
- Manufacturing readiness
- COST · TIMING
- —
Indian anthropometric sizing and the sensor layer
- UNLOCKS
- Fit for the target user; automatically tracked metrics
- COST · TIMING
- Phase 2
Phase-2 tooling
- UNLOCKS
- Volume production
- COST · TIMING
- ₹12–15 lakh
SOURCES
- [1]Orvyn engineering reports and first-order simulation — back support (v0.3); knee, ankle, footplate and strap (v0.4); knee load and fatigue simulation; design freeze at v0.6.0.
- [2]UNFPA India, India's Ageing Population: Why It Matters More Than Ever (2023–2024) — Indians aged 60 and over; wealth-quintile and income shares. https://india.unfpa.org/en/news/indias-ageing-population-why-it-matters-more-ever
- [3]de Souza et al., Prevalence of Low Back Pain in the Elderly Population: A Systematic Review, PMC6807687 — elderly low back pain prevalence. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6807687/
- [4]Functional Disability Due to Chronic Low Back Pain in the Geriatric Population of a Tertiary Care Hospital in North India (Safdarjung Hospital), PMC11137629 — severe functional disability among geriatric patients. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11137629/
- [5]What Do Older Adults Want From Spine Care?, PMC11170354 — first-person accounts of pain restricting activity; active independence as the central goal. https://pmc.ncbi.nlm.nih.gov/articles/PMC11170354/
- [6]Mordor Intelligence, Carbon Composites Market (2026) — carbon-fibre spot prices, 2022 to late 2024; automated-layup part-cost reductions, 2024–2025. https://www.mordorintelligence.com/industry-reports/carbon-composites-market
- [7]Orvyn cost, market and pilot model — price, bill of materials, contribution, margin, breakeven, sensitivity, acquisition cost, bottom-up market sizing and pilot design.
- [8]Oakon Tech / mona-care, Comparing Different Brands of Lower Limb Exoskeleton Robots — powered lower-limb medical exoskeleton pricing. https://www.mona-care.com/faq/comparing-different-brands-of-lower-limb-exoskelet.html
- [9]noonee, Chairless Chair 2.0 — passive occupational lower-body wearable chair for standing work. https://shop.noonee.com/en/products/chairless-chair-2-0
- [10]Archelis, Exoskeleton Report — passive chairless-chair lower-body exoskeleton for surgeons and industrial workers. https://exoskeletonreport.com/product/archelis/
- [11]Effect of a Passive Exosuit on Sit-to-Stand Performance in Geriatric Patients — A Pilot Study, PMC9867217 — sit-to-stand difficulty among older persons; sarcopenia as a driver. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867217/
BASIS & STAGE
Orvyn is design-frozen at CAD version 0.6.0 and exists as a specified design with first-order simulation. Every engineering figure comes from that simulation, not physical measurement, and the knee's 1.50× anti-buckle margin is unverified on hardware. No physical prototype has been built and no user has worn the device. The composite bill of materials is uncosted, its material and mass are not fixed, and the bench build has no date. The self-pay share has no India willingness-to-pay study behind it, and the pivot rests on clinical observation rather than a formal interview protocol. The next gate is a 5-unit bench build at ₹5–8 lakh over one build-and-test cycle.
PRODUCT RENDERS











